Clinical Trials
3 trialsNCT01589861 2026-04-21
PIKHER2
Institut Paoli-Calmettes
Phase 1/2 Terminated
NCT04338399 2025-11-17
BURAN
Adlai Nortye Biopharma Co., Ltd.
Phase 3 Completed
NCT04975958 2025-06-22
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
Adlai Nortye Biopharma Co., Ltd.
Phase 1 Completed